+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Neurothrombectomy Devices Market Report and Forecast 2023-2031

  • PDF Icon


  • 147 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5805767
The global neurothrombectomy devices market size attained a value of USD 631.6 million in 2022. The market is further expected to grow at a CAGR of 8.2% during the forecast period of 2023-2031 to attain a value of USD 1,278.6 million by 2031.

Neurothrombectomy Devices Market: Introduction

Neurothrombectomy devices are medical equipment used for the removal of blood clots (thrombi) from the neurovascular system, specifically within the cerebral arteries. These devices are essential in the treatment of acute ischemic stroke, where blood clots obstruct blood flow to the brain, leading to brain cell death and potentially severe neurological deficits.

The market for neurothrombectomy devices has been growing steadily due to a number of factors. The increase in stroke prevalence, especially in aging populations, is a major driver. Additionally, technological advancements in the design and functionality of these devices have significantly improved their efficiency and safety profile, thus promoting their use. The increasing awareness about the importance of rapid stroke treatment and the growing access to healthcare services worldwide also contribute to the growth of this market.

Benefits of Neurothrombectomy Devices:
  • Effective Stroke Treatment: Neurothrombectomy devices have been found to be effective in re-establishing blood flow to the brain in acute ischemic stroke patients, significantly improving outcomes
  • Minimally Invasive: The procedure to use these devices is minimally invasive, typically performed by entering a blood vessel in the groin and navigating to the brain, reducing the risks and recovery time compared to traditional surgery
  • Rapid Procedure: The use of these devices can quickly restore blood flow, which is critical since 'time is brain' in stroke treatment - the quicker blood flow can be restored, the more brain tissue can be saved
  • Technological Advancements: Modern neurothrombectomy devices, such as stent retrievers and aspiration catheters, have significantly improved in their ability to effectively and safely remove clots
  • Reduced Long-term Disability: By effectively treating strokes, these devices can significantly reduce long-term disability, improving quality of life and reducing healthcare costs
Despite these benefits, it is important to note that not all patients are suitable for neurothrombectomy. Factors like the size and location of the clot, the time since stroke onset, and the patient's overall health can influence the decision. Nevertheless, for suitable patients, neurothrombectomy devices offer a vital lifeline, making the continued evolution of this market essential for global health.

Neurothrombectomy Devices Market Segmentations

The market can be categorised into product type, type, end user, and region.

Market Breakup by Product Type

  • Clot Retrieval Devices
  • Aspiration Devices
  • Vascular Snares

Market Breakup by Type

  • Retriever
  • Integrated System

Market Breakup by End User

  • Hospitals
  • Clinics
  • Public Health Lab
  • Private or Commercial Labs
  • Physician Labs
  • Research Institutes
  • Others

Neurothrombectomy Devices Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Neurothrombectomy Devices Market Scenario

The neurothrombectomy devices market is experiencing a remarkable growth phase due to the increasing incidence of ischemic strokes and an aging global population. Strokes are one of the leading causes of morbidity and mortality worldwide, making the need for effective and rapid treatment strategies like neurothrombectomy more crucial than ever.

The market is characterized by continuous technological innovations that aim to improve the effectiveness, safety, and ease of use of neurothrombectomy devices. Manufacturers are investing heavily in research and development, resulting in the emergence of advanced devices like stent retrievers and aspiration catheters. These devices offer improved clot removal capabilities and have shown higher rates of successful revascularization and better clinical outcomes compared to earlier devices.

Geographically, the market is witnessing considerable growth in developed regions such as North America and Europe, driven by the high incidence of stroke, strong healthcare infrastructure, and the availability of skilled professionals. However, emerging markets in Asia Pacific and Latin America are also expected to witness significant growth due to increasing healthcare spending, improving healthcare infrastructure, and growing awareness about stroke and its treatment options.

The market is also characterized by the active role of regulatory bodies. While these organizations ensure the safety and efficacy of neurothrombectomy devices, their stringent regulations can also pose challenges to market players. Despite these challenges, the overall market trend is positive, reflecting the critical role of these devices in stroke treatment.

While the market has promising prospects, challenges such as the high cost of devices and procedures, lack of skilled professionals in developing regions, and potential risks and complications associated with neurothrombectomy may restrict market growth. Despite these challenges, the overall market outlook remains positive, driven by the dire need for effective stroke treatment options and continued technological advancement in the field.

Key Players in the Global Neurothrombectomy Devices Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the neurothrombectomy devices market are as follows:
  • Medtronic
  • Stryker
  • Phenox GmbH
  • Boston Scientific Corporation
  • Abbott
  • Terumo Corporation
  • W.L. Gore & Associatess, Inc
  • Vesalio, LLC
  • Teleflex Incorporated
  • Edwards Lifesciences Corporation
  • Koninklijke Philips N.V
  • Microport Scientific Corporation
  • Johnson & Johnson Private Limited

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Neurothrombectomy Devices Market Overview
3.1 Global Neurothrombectomy Devices Market Historical Value (2016-2022)
3.2 Global Neurothrombectomy Devices Market Forecast Value (2023-2031)
4 Global Neurothrombectomy Devices Market Landscape
4.1 Global Neurothrombectomy Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Neurothrombectomy Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Type
4.2.3 Analysis by End User
5 Global Neurothrombectomy Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Neurothrombectomy Devices Market Segmentation
6.1 Global Neurothrombectomy Devices Market by Product Type
6.1.1 Market Overview
6.1.2 Clot Retrieval Devices
6.1.3 Aspiration Devices
6.1.4 Vascular Snares
6.1.5 Others
6.2 Global Neurothrombectomy Devices Market by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Clinics
6.2.4 Ambulatory Surgical Centers
6.2.5 Others
6.3 Global Neurothrombectomy Devices Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Neurothrombectomy Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Neurothrombectomy Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Neurothrombectomy Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Neurothrombectomy Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Neurothrombectomy Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Medtronic
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Acandis GmbH
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Stryker
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Phenox GmbH
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Boston Scientific Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Abbott
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Terumo Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 W.L. Gore & Associatess, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Vesalio, LLC
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Teleflex Incorporated
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Edwards Lifesciences Corporation
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Koninklijke Philips N.V.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Microport Scientific Corporation
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Johnson & Johnson Private Limited
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Neurothrombectomy Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Medtronic
  • Acandis GmbH
  • Stryker
  • Phenox GmbH
  • Boston Scientific Corporation
  • Abbott
  • Terumo Corporation
  • W.L. Gore & Associatess Inc.
  • Vesalio LLC
  • Teleflex Incorporated
  • Edwards Lifesciences Corporation
  • Koninklijke Philips N.V.
  • Microport Scientific Corporation
  • Johnson & Johnson Private Limited



Table Information